Benjamin Levy, MD
Specialties:Internal Medicine, Hematology-Oncology
Dr. Levy is currently the Medical Director of Thoracic Medical Oncology for Mount Sinai Health Systems and the Associate Medical Director of the Cancer Clinical Trials Office (CCTO) for Mount Sinai Hospital. Dr Levy’s main focus is the comprehensive clinical care and research development for patients with thoracic malignancies, with particular emphasis on non-small cell lung cancer. In this effort, he has developed a robust clinical research portfolio that evaluates novel therapies including immunotherapy for lung cancer patients and is actively searching for genetic alterations that may predict sensitivity to such drugs. In addition to his clinical and research duties, Dr. Levy serves as Associate Editor for the ASCO University Committee where he helps develop educational web based content for oncologists across the country. He currently serves on the editorial board for the Journal of Clinical Oncology (JCO) and serves as an ad hoc reviewer for other journals including Clinical Lung Cancer and The Oncologist. Dr Levy actively publishes in peer review journals including Journal of the National Comprehensive Cancer Network (JNCCN), Journal of Oncology Practice (JOP), and the Journal of Thoracic Oncology (JTO).
In the News:
Dr. Levy discusses the role of adjuvant chemotherapy versus neoadjuvant chemotherapy for patients with NSCLC undergoing surgical resection with curative intent.
Dr. Levy discusses strategies for delivering maintenance therapy in NSCLC.
Dr. Levy Provides Update on Squamous Cell Lung Cancer Treatments.
Dr. Levy sits down with Selma Schimmel in The Group Room to discuss next generation sequencing in lung cancer.
MD, Medical College of Georgia
Residency, Internal Medicine, Georgetown University Hospital
Fellowship, Hematology & Onc., New York Presbyterian - Weill Cornell Medical Center
Young Investigators Award (YIA) - 2009
Research Fellow of the Year - 2008
Dan Printup Memorial Scholarship - 1998